CoChat

4-Hydroxynonenal-modified amyloid-β peptide inhibits the proteasome: possible importance in Alzheimer’s disease*

Open access
Shringarpure, R., Grune, T., Sitte, N., Davies*, K. J. A. · 2000 · Cellular and Molecular Life Sciences

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

The amyloid beta-peptide (Abeta) is a 4-kDa species derived from the amyloid precursor protein, which accumulates in the brains of patients with Alzheimer's disease. Although we lack full understanding of the etiology and pathogenesis of selective neuron death, considerable data do imply roles for both the toxic Abeta and increased oxidative stress. Another significant observation is the accumulation of abnormal, ubiquitin-conjugated proteins in affected neurons, suggesting dysfunction of the proteasome proteolytic system in these cells. Recent reports have indicated that Abeta can bind and inhibit the proteasome, the major cytoslic protease for degrading damaged and ubiquitin-conjugated proteins. Earlier results from our laboratory showed that moderately oxidized proteins are preferentially recognized and degraded by the proteasome; however, severely oxidized proteins cannot be easily degraded and, instead, inhibit the proteasome. We hypothesized that oxidatively modified Abeta might have a stronger (or weaker) inhibitory effect on the proteasome than does native Abeta. We therefore also investigated the proteasome inhibitory action of Abeta1-40 (a peptide comprising the first 40 residues of Abeta) modified by the intracellular oxidant hydrogen peroxide, and by the lipid peroxidation product 4-hydroxynonenal (HNE). H2O2 modification of Abeta1-40 generates a progressively poorer inhibitor of the purified human 20S proteasome. In contrast, HNE modification of Abeta1-40 generates a progressively more selective and efficient inhibitor of the degradation of fluorogenic peptides and oxidized protein substrates by human 20S proteasome. This interaction may contribute to certain pathological manifestations of Alzheimer's disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/pl00000660

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A b 1-40 inhibits proteasome chymotrypsin-like activity. The chymotrypsin-like activity of the proteasome was monitored by measuring degradation of the fluorogenic peptide substrate, suc-LLVY-MCA in the presence of increasing concentrations of A b 1-40 . Data are represented as percent inhibition (means 9 SEs of three independent experiments).
Figure 1 A b 1-40 inhibits proteasome chymotrypsin-like activity. The chymotrypsin-like activity of the proteasome was monitored by measuring degradation of the fluorogenic peptide substrate, suc-LLVY-MCA in the presence of increasing concentrations of A b 1-40 . Data are represented as percent inhibition (means 9 SEs of three independent experiments).From the PDF
Figure 2 Effects of oxidative modification on the proteolytic susceptibility of hemoglobin. [ 3 H]-hemoglobin was exposed to various concentrations of hydrogen peroxide, microconcentrated, and then incubated for 1 h at 37 °C with purified human proteasome, to measure proteolytic susceptibility. All data are the means and SEs of three experiments.
Figure 2 Effects of oxidative modification on the proteolytic susceptibility of hemoglobin. [ 3 H]-hemoglobin was exposed to various concentrations of hydrogen peroxide, microconcentrated, and then incubated for 1 h at 37 °C with purified human proteasome, to measure proteolytic susceptibility. All data are the means and SEs of three experiments.From the PDF
Figure 3 Effects of A b 1-40 on the degradation of native and oxidized hemoglobin by the proteasome. A b 1-40 was oxidized as described in Materials and methods. Purified proteasome was incubated with various concentrations of oxidized A b 1-40 for 1 h at room temperature. Next, native [ 3 H]-Hb or [ 3 H]-Hb oxidized with H2O2 was added, and proteolysis was allowed to proceed for 1 h at 37 °C. Percent hemoglobin degradation was calculated as described in Materials and methods. Data are represented as means 9 SEs of triplicate samples from a total of four experiments. ( A ) Percent degradation of both native and oxidized (20 mM H2O2) [ 3 H]-hemoglobin by the purified human 20S proteasome, in the presence of native A b 1-40 . ( B ) Effect of oxidized A b 1-40 (30 mM H2O2) on the degradation of both native and oxidized (20 mM H2O2) hemoglobin by the proteasome.
Figure 3 Effects of A b 1-40 on the degradation of native and oxidized hemoglobin by the proteasome. A b 1-40 was oxidized as described in Materials and methods. Purified proteasome was incubated with various concentrations of oxidized A b 1-40 for 1 h at room temperature. Next, native [ 3 H]-Hb or [ 3 H]-Hb oxidized with H2O2 was added, and proteolysis was allowed to proceed for 1 h at 37 °C. Percent hemoglobin degradation was calculated as described in Materials and methods. Data are represented as means 9 SEs of triplicate samples from a total of four experiments. ( A ) Percent degradation of both native and oxidized (20 mM H2O2) [ 3 H]-hemoglobin by the purified human 20S proteasome, in the presence of native A b 1-40 . ( B ) Effect of oxidized A b 1-40 (30 mM H2O2) on the degradation of both native and oxidized (20 mM H2O2) hemoglobin by the proteasome.From the PDF
Image 4
From the PDF
Figure 4 Oxidation of A b 1-40 inactivates its ability to inhibit the proteasome. Shown is the progressive oxidation of A b 1-40 as measured by carbonyl production with exposure to increasing concentrations of H2O2 ( A ) and that increasing oxidation progressively inactivates the ability of A b 1-40 to inhibit degradation of both native and oxidized hemoglobin by the proteasome ( B ). Carbonyl measurements, exposure of A b 1-40 and hemoglobin to H2O2, and calculation of percent hemoglobin degradation were performed as described in Materials and methods. Data are represented as means and SEs from four experiments. ( A , B ) The extent of A b oxidation was varied by pre-exposure to 0-30 mM hydrogen peroxide. ( B ) Purified human 20S proteasome was incubated with progressively oxidized A b for 1 h at room temperature. Next, native [ 3 H]-Hb or [ 3 H]-Hb oxidized with 20 mM H2O2 was added and proteolysis was allowed to proceed for 1 h at 37 °C.
Figure 4 Oxidation of A b 1-40 inactivates its ability to inhibit the proteasome. Shown is the progressive oxidation of A b 1-40 as measured by carbonyl production with exposure to increasing concentrations of H2O2 ( A ) and that increasing oxidation progressively inactivates the ability of A b 1-40 to inhibit degradation of both native and oxidized hemoglobin by the proteasome ( B ). Carbonyl measurements, exposure of A b 1-40 and hemoglobin to H2O2, and calculation of percent hemoglobin degradation were performed as described in Materials and methods. Data are represented as means and SEs from four experiments. ( A , B ) The extent of A b oxidation was varied by pre-exposure to 0-30 mM hydrogen peroxide. ( B ) Purified human 20S proteasome was incubated with progressively oxidized A b for 1 h at room temperature. Next, native [ 3 H]-Hb or [ 3 H]-Hb oxidized with 20 mM H2O2 was added and proteolysis was allowed to proceed for 1 h at 37 °C.From the PDF
Figure 5 Cross-linking of A b 1-40 with exposure to HNE. A b 1-40 was modified with various concentrations of HNE and separated by 15% SDS-PAGE. The bands were visualized by staining with Coomassie blue.
Figure 5 Cross-linking of A b 1-40 with exposure to HNE. A b 1-40 was modified with various concentrations of HNE and separated by 15% SDS-PAGE. The bands were visualized by staining with Coomassie blue.From the PDF
Figure 6 HNE-modified A b 1-40 inhibits the chymotrypsin-like activity of the proteasome. A b 1-40 was modified with 50 and 100 m M HNE as described in Materials and methods. Degradation of the fluorogenic substrates suc-LLVY-MCA ( A ) and z-LLL-MCA ( B ) was measured in the presence of HNE-modified A b 1-40 . Where used, A b 1-40 or HNE were added to purified human 20S proteasome at the same time as suc-LLVY-MCA or z-LLL-MCA, without any pre-incubation. This precaution was taken to prevent possible reactions of HNE with the proteasome. Data are represented as means 9 SEs of three independent experiments.
Figure 6 HNE-modified A b 1-40 inhibits the chymotrypsin-like activity of the proteasome. A b 1-40 was modified with 50 and 100 m M HNE as described in Materials and methods. Degradation of the fluorogenic substrates suc-LLVY-MCA ( A ) and z-LLL-MCA ( B ) was measured in the presence of HNE-modified A b 1-40 . Where used, A b 1-40 or HNE were added to purified human 20S proteasome at the same time as suc-LLVY-MCA or z-LLL-MCA, without any pre-incubation. This precaution was taken to prevent possible reactions of HNE with the proteasome. Data are represented as means 9 SEs of three independent experiments.From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 141

Metadata

Authors
Shringarpure, R., Grune, T., Sitte, N., & Davies*, K. J. A.
Affiliations
  • University of Southern California (US)
  • Humboldt-Universität zu Berlin (DE)
Venue
Cellular and Molecular Life Sciences
Published
2000-10
Volume
57
Issue
12
Pages
1802-1809
ISSN
1420-682X (ISSN-L)
OpenAlex
W2097355576
Cited by
140
References
35
Citations by year
2025: 2 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 9
FWCI
4.91
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Cellular and Molecular Life Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Environmental Health Sciences (ES03598)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
amyloid-beta, 4-hydroxynonenal, proteasome inhibition, Alzheimer's disease, oxidative stress, hydrogen peroxide, lipid peroxidation, 20S proteasome, protein oxidation, Aβ40, fluorogenic peptide substrates
MeSH terms
Aldehydes, Alzheimer Disease, Cysteine Endopeptidases, Erythrocytes, Hemoglobins, Humans, Hydrogen Peroxide, Multienzyme Complexes, Oxidation-Reduction, Oxyhemoglobins, Peptide Fragments, Protease Inhibitors, Lipid Peroxidation, Amyloid beta-Peptides, Proteasome Endopeptidase Complex, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.